CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)	3 Months Ended		9 Months Ended
	Dec. 31, 2016	Dec. 31, 2015	Dec. 31, 2016	Dec. 31, 2015
Net revenues	$ 15,674,876	$ 10,659,708	$ 42,669,205	$ 32,233,441
Costs and expenses
Cost of services	12,715,864	8,463,541	35,020,052	24,295,598
General and administrative	4,485,932	3,510,045	12,777,736	11,187,891
Depreciation and amortization	148,934	145,594	484,147	287,029
Total costs and expenses	17,350,730	12,119,180	48,281,935	35,770,518
Loss from operations	(1,675,854)	(1,459,472)	(5,612,730)	(3,537,077)
Other (expense) income
Interest expense	(9,993)	(100,983)	(15,706)	(530,203)
Change in fair value of warrant and conversion feature liabilities	300,000	430,396	1,633,333	313,530
Loss on debt extinguishment	0	(266,364)	0	(266,364)
Other income (expense)	888	(100,344)	13,419	(94,431)
Total other income (expense), net	290,895	(37,295)	1,631,046	(577,468)
Loss before provision for (benefit from) income taxes	(1,384,959)	(1,496,767)	(3,981,684)	(4,114,545)
Provision for (benefit from) income taxes	99,516	36,196	(127,077)	(57,251)
Net loss	(1,484,475)	(1,532,963)	(3,854,607)	(4,057,294)
Net income attributable to noncontrolling interest	(248,231)	(152,648)	(551,765)	(642,050)
Net loss attributable to Apollo Medical Holdings, Inc.	$ (1,732,706)	$ (1,685,611)	$ (4,406,372)	$ (4,699,344)
Net loss per share:
Basic and diluted	$ (0.29)	$ (0.31)	$ (0.74)	$ (0.93)
Weighted average number of shares of common stock outstanding:
Basic and diluted	6,033,518	5,365,563	5,991,260	5,031,389